1. Home
  2. SLGL vs VNCE Comparison

SLGL vs VNCE Comparison

Compare SLGL & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • VNCE
  • Stock Information
  • Founded
  • SLGL 1997
  • VNCE 2002
  • Country
  • SLGL Israel
  • VNCE United States
  • Employees
  • SLGL N/A
  • VNCE N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • SLGL Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • SLGL 21.1M
  • VNCE 20.2M
  • IPO Year
  • SLGL 2018
  • VNCE 2013
  • Fundamental
  • Price
  • SLGL $7.24
  • VNCE $1.48
  • Analyst Decision
  • SLGL Buy
  • VNCE Strong Buy
  • Analyst Count
  • SLGL 1
  • VNCE 3
  • Target Price
  • SLGL $40.00
  • VNCE $4.33
  • AVG Volume (30 Days)
  • SLGL 13.2K
  • VNCE 26.1K
  • Earning Date
  • SLGL 05-23-2025
  • VNCE 06-17-2025
  • Dividend Yield
  • SLGL N/A
  • VNCE N/A
  • EPS Growth
  • SLGL N/A
  • VNCE N/A
  • EPS
  • SLGL N/A
  • VNCE N/A
  • Revenue
  • SLGL $12,103,000.00
  • VNCE $293,452,000.00
  • Revenue This Year
  • SLGL N/A
  • VNCE $1.54
  • Revenue Next Year
  • SLGL $31.17
  • VNCE $3.74
  • P/E Ratio
  • SLGL N/A
  • VNCE N/A
  • Revenue Growth
  • SLGL 603.66
  • VNCE 0.19
  • 52 Week Low
  • SLGL $3.34
  • VNCE $1.27
  • 52 Week High
  • SLGL $16.50
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 50.26
  • VNCE 41.85
  • Support Level
  • SLGL $7.15
  • VNCE $1.45
  • Resistance Level
  • SLGL $7.45
  • VNCE $1.64
  • Average True Range (ATR)
  • SLGL 0.32
  • VNCE 0.09
  • MACD
  • SLGL -0.10
  • VNCE -0.00
  • Stochastic Oscillator
  • SLGL 31.36
  • VNCE 29.03

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: